ARCHIVES

Central Oncology Group Phase Out Approved; Board Impressed By Unanimous CCIRC Vote

This article is from The Cancer Letter archive.

Vol. 02 No. 14 | April 2, 1976

Download PDF Visit The Full Archive

Related Articles

FDA Approves Xeloda For Breast Cancer After Failure Of Anthracycline Treatment.

September 28, 2001

Two Cooperative Groups Renamed ECOG-ACRIN

September 23, 2011

Zaltrap Shows Improvement in Survival In Stage IV Metastatic Colorectal Cancer

July 29, 2011

Implantable Drug Delivery Device Offers Better Pain Relief

September 27, 2002

NCI Advisory Group, Other Cancer Meetings For Feb., March Listed

January 25, 1991

NC-Approved Clinical Trials

June 27, 2003